WAY vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

WAY

34.7
AI Score
VS
PACS Wins

PACS

38.0
AI Score

Investment Advisor Scores

WAY

35score
Recommendation
AVOID NEW MONEY

PACS

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric WAY PACS Winner
Forward P/E 14.5773 18.7617 WAY
PEG Ratio 0 1.2502 Tie
Revenue Growth 21.2% 11.5% WAY
Earnings Growth -5.9% 15.6% PACS
Tradestie Score 34.7/100 38.0/100 PACS
Profit Margin 10.7% 4.9% WAY
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

WAY 1M: +9.7% · 3M: +15.0% PACS 1M: +12.8% · 3M: +11.3%

Current Technical Phase

WAY

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.0% over 20 days), RSI 56

RSI (14): 55.8 · Price: $28.84

PACS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.2% over 20 days), RSI 60

RSI (14): 60.5 · Price: $50.06

Fundamentals Snapshot

Metric WAY PACS
Market Cap — —
Forward P/E 15.3 17.6
Trailing P/E 42.5 27.7
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.7% 0.2%
Operating Margin 0.2% 0.1%
EPS 0.69 1.77
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.